Navigation Links
Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
Date:3/22/2013

HAYWARD, Calif., March 22, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced its abstract entitled "Blisibimod, an Emerging Subcutaneous Biologic Therapy for Patients with Active, Moderate-to-Severe Systemic Lupus Erythematosus," has been selected as an oral presentation and will be presented at the 10th International Congress on Systemic Lupus Erythematosus by Dr. Morton Scheinberg , a rheumatologist at the Hospital Abreu Sodre Pesquisa Clinica in Sao Paulo, Brazil, on April 20, 2013.

Additionally, a poster entitled "Clinical Experience in Latin America With Blisibimod Amongst Subjects with Active, Moderate-to-Severe Systemic Lupus Erythematosus: Data From The Phase 2b PEARL-SC Study," will be presented by Dr. Scheinberg as part of the conferences Guided Poster Tours on April 19, 2013.

The poster will be available on www.anthera.com.

About Blisibimod and PEARL-SC

BAFF has been associated with a wide range of B-cell-mediated autoimmune diseases, including systemic lupus erythematosus, vasculitis, IgA nephropathy, immune thrombocytopenic purpura and others. Multiple clinical studies with other BAFF antagonists recently have reported on BAFF inhibitors potential positive role in treating lupus and rheumatoid arthritis. Anthera is advancing its development of blisibimod, a selective inhibitor of BAFF, to expand its potential clinical utility in autoimmune diseases. Blisibimod is a novel fusion protein called a peptibody and is distinct from an antibody. Anthera owns worldwide rights to blisibimod in all potential indications.  The PEARL-SC Phase 2 study was designed as a ran
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
2. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
3. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
5. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
7. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
8. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
9. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
10. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
11. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , Chine, 3 juillet 2015 BGI ... à haut débit de l,ADN situé à ... certification de  l,American College of Pathologists  (Collège des ... à Hong Kong constituent ... génération à recevoir la certification du CAP en ...
(Date:7/2/2015)... FORT LAUDERDALE, Fla. , July 2, 2015 ... & Co., is pleased to announce that its ... Inc. ("Insight Beverages") to Kerry Group plc (ISE: ... focused on taste and nutrition systems, as well ... food, beverage and pharmaceutical markets. Farlie Turner served ...
(Date:7/2/2015)... DUBLIN , June 26, 2015 ... of the "Vitamin D Market by Analog, Application, End-User ... report to their offering. This market is ... use of vitamin D in different applications and rising opportunities ... China , Italy , and ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... Sept. 9 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... Triax Pharmaceuticals, LLC announced today the ... strength of tretinoin; Tretin-X 0.0375%, for the treatment of ... that offers a between strength – effective ... hydrating cream vehicle. For those patients already on tretinoin ...
Cached Medicine Technology:Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 2Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 3Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 4Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 5Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 6Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 7Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 8New, Exclusive Strength: Tretin-X® 0.0375%(tretinoin) Cream 2
(Date:7/4/2015)... ... 2015 , ... Chronic Neck Pain. Neck pain is no small ... the neck. Another 19% suffer from head, migraine, or facial pain, in some cases ... of American workers must deal with neck pain. Strategies for mitigating neck ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June 30th SEO ... SEO training system called "Page One Engine" . The program, which has ... glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the largest ... MD as the new Medical Director of its Frisco facility. , “We are pleased ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2
... pharmaceutical community, VIENNA, Va., Feb. 11 ... http://www.convera.com, a leading provider of vertical,search ... of,PharmaLiveSearch.com, a vertical search site specific to ... with Canon,Communications Pharmaceutical Media Group., ...
... of Directors as Chairman, NASHVILLE, Tenn., Feb. ... General Atlantic LLC (General,Atlantic) and affiliates of Hellman ... interests in Emdeon held by HLTH Corporation (Nasdaq:,HLTH). ... from HLTH in,November 2006., Emdeon also announced ...
... #1 FOR IMMEDIATE RELEASE , Recordable ... , Move over, compact discs, DVDs, and hard drives. ... protein-based memory device that could provide an alternative to ... approaching their memory storage capacities. Their study is scheduled ...
... Corporation,of America (Nasdaq: DCAI ) announced the ... Delaware County, Ohio which began construction,late last year, ... Everett commented, "Our newest facility in Ohio,opened earlier ... zero,deficiencies. The facility is in partnership with physicians ...
... to complementary or alternative medicine may not be accurate, ... -- Just 5 percent of Web pages devoted to ... complementary or alternative medicine are 15 times more likely ... a new study says. , Moreover, standard measures of ...
... to improve,prostate cancer imaging, WASHINGTON, Feb. 11 ... the Department of Health and Human,Services (HHS) and ... high priority" in the current for research and ... treatment of prostate,cancer. Such a federal investment in ...
Cached Medicine News:Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 2Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 2Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 9Health News:Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio 2Health News:Most Breast Cancer Web Pages Contain Reliable Information 2Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 2Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 3Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 4
Our Reticulocyte Stain is a specialized hematology stain for identifying immature erythrocytes. These immature erythrocytes stain blue in a fine mesh network within the erythrocyte. Mature erythrocyt...
The Buffered Wright Stain is a single solution stain that contains the fixative, buffer, and stain for rapid and convenient staining of blood smears. It is packaged in a 32-oz. bottle for ease of use...
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast....
Albumin (BCG). Storage temp: 15 -30 C. Linearity: 0.5 - 6.0 g/dl. Expected values: 3.5 - 5.5 g/dl. Available with calibrator. Performs 500 number of tests....
Medicine Products: